Sort By

INSIGHTEC announced on Wednesday that the FDA has approved the relabeling of the Exablate system to treat women with symptomatic uterine fibroids who want to spare their uterus and maintain fertility. Exablate can now be used for both women who are “family complete” and those who still want to conceive. Link to article

Font Resize